Supplementary Materials for: Novel TYK2 inhibitor D-2570 in moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase 2 trial

This dataset contains supplementary materials for the following publication: Novel TYK2 inhibitor D-2570 in moderate to severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase 2 trial published in the Journal of the American Academy of Dermatology. Supplementary materials include supplementary methods, 3 supplementary figures, and 4 supplementary tables.本数据集包含下述发表论文的补充材料：发表于《美国皮肤病学会杂志》、题为《新型TYK2抑制剂D-2570治疗中重度斑块状银屑病：一项随机双盲安慰剂对照2期临床试验》的研究。补充材料涵盖补充方法、3张补充图及4张补充表。